logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
arrow
BackJournal Details
Vaccine cover

Vaccine

IF3.5
Papers2208
Citations47204
Journal Papers 2208
Publication Date
delete
End-of-season influenza vaccine effectiveness against a(H3N2) and B/Victoria in Beijing, China, 2025/26 season
deleteVaccine
IF3.5
delete2026-10-28
delete0
PREAI
deleteJiaojiao Zhang; Ying Shen; Weixian Shi; Jiaxin Ma; Jiachen Zhao; Chunna Ma; Dan Wu; Yingying Wang; Guilan Lu; Lu Zhang; Yimeng Liu; Wei Duan; Weijia Zhang; Xiaodi Hu; Hui Xu; Quanyi Wang; Peng Yang; Daitao Zhang
deleteShare
deleteSave
Boosting hybrid immunity with intranasal live-attenuated or intramuscular mRNA vaccination prevents SARS-CoV-2 XBB.1.5 transmission
deleteVaccine
IF3.5
delete2026-10-28
delete0
deleteOAAI
deleteJana Kochmann; Nico Joel Halwe; G. Tuba Barut; Nadine Ebert; Volker Thiel; Anca Dorhoi; Donata Hoffmann; Martin Beer; Jacob Schön; Björn Corleis
deleteShare
deleteSave
Exposure to natural disasters and vaccination indicators: a systematic review and directions for future research
deleteVaccine
IF3.5
delete2026-10-27
delete0
deleteOAAI
deleteBrittany Shea; Jeffrey Shaman
deleteShare
deleteSave
Hemagglutinin- and neuraminidase-targeting antibody responses after receipt of egg-based inactivated or recombinant influenza vaccines among adults aged 18–64 years
deleteVaccine
IF3.5
delete2026-10-27
delete0
deleteOAAI
deleteVasiliy P. Mishin; Mira C. Patel; Rongyuan Gao; Lauren Grant; Anton Chesnokov; Philippe Noriel Q. Pascua; Ha T. Nguyen; Chloe Champion; Kurt T. Hegmann; Matthew S. Thiese; Colin Maguire; Sarang K. Yoon; Lori S. Merrill; Rebecca V. Fink; Andrew L. Phillips; Shivaprakash Gangappa; Kristina Wielgosz; Min Z. Levine; Fatimah S. Dawood; Larisa V. Gubareva
deleteShare
deleteSave
Childhood vaccination timeliness, under-immunization-for-age and measles effective immunity in Peru: a province and birth-cohort analysis of national survey data, 2004–2025
deleteVaccine
IF3.5
delete2026-10-27
delete0
deleteOAAI
deleteJesús D. Rojas; Carolina R. Huarachi-Napa; Stephanie Z. Salazar-Buitron; Angelo P. Quillo-Diaz; Roger I. Calderón
deleteShare
deleteSave
Faster waning of immunity to influenza vaccine strains reintroduced into subsequent seasons: A human cohort study
deleteVaccine
IF3.5
delete2026-10-27
delete0
deleteOAAI
deleteCong Cheng; Xianyan Chen; Yang Ge; Meng-Hsuan Sung; Jiahui Zuo; Michael A. Carlock; Hannah B. Hanley; Ted M. Ross; Andreas Handel; Ye Shen
deleteShare
deleteSave
mRNA vaccine encoding multimerized AIV-M2e fused to MHC-II invariant chain motif and Pan-DR epitope confers protection against H9N2 virus in chickens
deleteVaccine
IF3.5
delete2026-10-26
delete0
PREAI
deleteSandeep Yadav; Aparna Varma; Shraman Jana; Samiran Mondal; Shayan Sharif; Amirul Islam Mallick
deleteShare
deleteSave
mRNA encoding norovirus VP1 produces antigenically functional virus-like particles in vitro
deleteVaccine
IF3.5
delete2026-10-26
delete0
deleteOAAI
deleteJudith M. Reyes Ballista; Courtney David; Amanda Pirrone; Estibaliz Gonzalez-Fernandez; Jiajie Wei; Zhiyun Wen
deleteShare
deleteSave
Monitoring of adverse events following 2024–2025 BNT162b2 KP.2 COVID-19 vaccination in the United States
deleteVaccine
IF3.5
delete2026-10-26
delete0
deleteOAAI
deleteJenny W. Sun; Laura E. Dodge; Shijie Cai; Li Zhou; Florence T. Wang
deleteShare
deleteSave
An exploratory study of gut microbiota and humoral immune responses following bacterial ghost administration in rats
deleteVaccine
IF3.5
delete2026-10-24
delete0
PREAI
deleteAiswarya Pradeep; Asish Issac Mathew; Sayuj Koyyappurath; Praveen Kumar Vemula; Sarita Ganapathy Bhat; Sreeja Narayanan
deleteShare
deleteSave
Hospital-based surveillance of vaccine-preventable diseases in children: a retrospective study in a Dutch tertiary hospital (2024–2025)
deleteVaccine
IF3.5
delete2026-10-24
delete0
PREAI
deleteSusanne Heemskerk; Veerle Roels; Jojanneke van Summeren; Louis J. Bont; Joanne G. Wildenbeest
deleteShare
deleteSave
In silico conservation and HLA-binding profiles of HMPV F and G protein epitopes: implications for universal vaccine development
deleteVaccine
IF3.5
delete2026-10-23
delete0
deleteOAAI
deleteLora Lee Pless; Marissa Pacey Griffith; Kady D. Waggle; Hunter Coyle; Alison Spratt; Alonzo B. Beatty; Monika Johnson; Evan Michael Heffelfinger; Helen Eleni Aslanidou D'Agostino; Michael Susick; Gabriella Alicea; G.K. Balasubramani; Richard K. Zimmerman; Mary Patricia Nowalk; John Williams; Lee H. Harrison
deleteShare
deleteSave
Brazilian version of the Vaccine Trust Gauge for adolescents
deleteVaccine
IF3.5
delete2026-10-23
delete0
deleteOAAI
deleteVanessa Mara da Silva; Liza Motta Lima; Matheus Correia da Silva; Jaqueline Costa Lima; Juliano Bortolini; Scott C. Ratzan; Ana Lucia Sartori; Bruna Hinnah Borges Martins de Freitas
deleteShare
deleteSave
Sex differences in human papillomavirus vaccination among Japanese university students and associated factors: a cross-sectional study examining the mediating effect of knowledge and interactions
deleteVaccine
IF3.5
delete2026-10-22
delete0
PREAI
deleteChieko Yodawara; Yoko Iio; Harumi Ejiri; Yukihiro Mori; Manato Seguchi; Yuka Aoyama; Morihiro Ito
deleteShare
deleteSave
Development and analytical characterization of a 24-plex microsphere-based assay for the quantitation of the antibodies against pneumococcal vaccine serotypes
deleteVaccine
IF3.5
delete2026-10-21
delete0
deleteOAAI
deleteYumiko Hayashi; Kaja Abbas; Bhim Gopal Dhoubhadel
deleteShare
deleteSave
Phase 2 trial to evaluate the safety and immunogenicity of a 25-valent pneumococcal conjugate vaccine (IVT-PCV25) in infants
deleteVaccine
IF3.5
delete2026-10-21
delete0
deleteOAAI
deleteLulu Bravo; Nancy Bermal; Edison Alberto; January Anne Pardo; Maria Angela Maronilla; Maria Christine Joy Tanteo; Sue Ann Clemens; Frank W. Rockhold; Indah Andi-Lolo; Rohan J. Vilms; Sybil A. Tasker; Ralf L. Clemens; Subhash Kapre; Astrid Borkowski
deleteShare
deleteSave
Cross-protection and type-replacement over the 17 years after human papillomavirus vaccine introduction in young women
deleteVaccine
IF3.5
delete2026-10-20
delete0
PREAI
deleteJessica A. Kahn; Aaron Ermel; Lili Ding; Aislinn DeSieghardt; Sem Yao; Darron Brown; Casey Dagnall; Amrit Bhatia; Eduardo L. Franco
deleteShare
deleteSave
Quantifying the impact of pathogen interactions on vaccine effectiveness estimates in the test-negative design
deleteVaccine
IF3.5
delete2026-10-20
delete0
PREAI
deleteZibin Cai; Linli Wang; Shuyi Ji; Xuan Deng; Lingxian Qiu; Shenyu Wang; Hao Lei
deleteShare
deleteSave
Designing sero-epidemiological studies to explore immune markers associated with a reduced risk of invasive Klebsiella pneumoniae disease
deleteVaccine
IF3.5
delete2026-10-19
delete0
deleteOAAI
deleteZiyaad Dangor; Ruchita Balasubramanian; Alane Izu; Courtney Olwagen; Kirsty Le Doare; James A. Berkley; David Goldblatt; Nicole Benson; Padmini Srikantiah; Shabir A. Madhi
deleteShare
deleteSave
AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication
deleteVaccine
IF3.5
delete2026-10-18
delete0
deleteOAAI
deleteArtem Krokhin; Julia Romanova; Regina Grillari; Matthias Hackl; Pavel Korabliov; Jozef Mandík; Andrej Egorov
deleteShare
deleteSave